How much funding has Serinus Biosciences raised?

Serinus Biosciences has raised $500K in total funding, most recently a Pre-Seed round.

When was Serinus Biosciences founded?

Serinus Biosciences was founded in 2022.

Where is Serinus Biosciences headquartered?

Serinus Biosciences is headquartered in New York, New York, United States.

What industry is Serinus Biosciences in?

Serinus Biosciences operates in Biotech, Healthcare, Oncology, Therapeutics.

How many employees does Serinus Biosciences have?

Serinus Biosciences has 1-10 employees.

Serinus Biosciences

Q: Who are Serinus Biosciences's investors?

Serinus Biosciences's investors include Y Combinator Continuity Fund, Illumina Ventures, Endless Frontier Labs.

Combinations therapy by rational design

New York, United States · Founded 2022 · $500K raised

YC S22

Headquarters: New York, New York
Employees: 1–10
Founded: 2022
Website: serinus.bio

Total Funding: $500K
Last Round: $500K Pre-SeedSep 2022
Rounds: 1

About

Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.

Summary

Serinus Biosciences is a Biotech company based in New York, United States, founded in 2022. It has raised $500K in total across 1 round, most recently a $500K Pre-Seed round in Sep 2022. Investors include Y Combinator Continuity Fund, Illumina Ventures and Endless Frontier Labs.